H2020FP7HORIZON
Servicio Madrileno de Salud
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 131
- As coordinator
- 9
- EU contribution (CORDIS)
- EUR 62,393,942
- Active
- 2008 to 2025
Projects
131 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| MID-FRAIL-STUDYA RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MID-FRAIL STUDY | FP7 | 2012 | Coordinator | EUR 1,347,894 |
| ECRIN-IAEuropean Clinical Research Infrastructures Network - Integrating Activity | FP7 | 2012 | Participant | EUR 28,413 |
| SENATORDevelopment and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and non-drug Therapy in Older peRsons | FP7 | 2012 | Participant | EUR 599,819 |
| RENEBRealizing the European Network in Biodosimetry | FP7 | 2012 | Participant | EUR 17,976 |
| E-PREDICEEarly Prevention of Diabetes Complications in people with Hyperglycaemia in Europe | FP7 | 2012 | Participant | Not stated |
| EVOTAREvolution and Transfer of Antibiotic Resistance | FP7 | 2011 | Participant | EUR 992,036 |
| MesendotRegulation of mesenchymal stem cells by vasculature and enhancement of their regenerative potential for the treatment of acute myocardial infarction | FP7 | 2011 | Coordinator | EUR 230,980 |
| NEO-CIRCDobutamine for NEOnatal CIRCulatory failure defined by novel biomarkers | FP7 | 2011 | Participant | EUR 519,062 |
| BAMIThe effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction | FP7 | 2011 | Participant | EUR 540,711 |
| AIPGENEAugmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria | FP7 | 2011 | Participant | EUR 45,400 |
| CANCERALIADevelopment of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours | FP7 | 2011 | Participant | EUR 183,902 |
| R-GNOSISResistance in Gram-Negative Organisms: Studying Intervention Strategies | FP7 | 2011 | Participant | EUR 385,922 |
| OPTIMISEOPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) | FP7 | 2010 | Participant | EUR 742,961 |
| EBM CONNECTEvidence-based Medicine COllaboratioN NEtwork for guideline development, teaChing and disseminaTion | FP7 | 2010 | Participant | EUR 39,600 |
| AMI-4EUROPEAdvanced, Cross-Disciplinary & Integrated Medical Imaging for all Europeans through a Network of Regional Clusters and Development Strategies | FP7 | 2010 | Participant | EUR 138,312 |
| NEOMEROEuropean multicenter network to evaluate pharmacokinetics, safety and efficacy of Meropenem in neonatal sepsis and meningitis | FP7 | 2010 | Participant | EUR 194,501 |
| EU-GEIEuropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions | FP7 | 2010 | Participant | EUR 1,181,892 |
| EFACTSEuropean Friedreich's Ataxia Consortium for Translational Studies | FP7 | 2010 | Participant | EUR 54,000 |
| PARPredicting antibiotic resistance | FP7 | 2010 | Participant | EUR 500,000 |
| FOD-CCFRAILTY OPERATIVE DEFINITION-CONSENSUS CONFERENCE | FP7 | 2010 | Coordinator | EUR 251,420 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.